RE:Projected cash position below 1.5M CAD at June 30th .....750k in warrants exercised in May for $.225 M
3.165 M warrants exercisable @$0.50 in October for potential $1.58 M
4.095 M warrants exercisable @$0.50 in Jan 2023 for potential $2.05 M
There will be 10.3 M stock options exercisable by Sep at an average strike price of $0.26/share potentially worth up to $2.68 M
There are still more than 2 M in broker shares exercisable at $0.30 left over from the financing.
I fully expect the October and January warrants will be exercised as the share price rises in anticipation of the BTD application and then approval by the FDA.
I think a lot of the 2022 expenses were front loaded in Q1 - just a guess based on the financials.